132 related articles for article (PubMed ID: 17687725)
21. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
22. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
[TBL] [Abstract][Full Text] [Related]
23. The molecular pathogenesis of treatment-induced (secondary) leukemias: foundations for treatment and prevention.
Karp JE; Smith MA
Semin Oncol; 1997 Feb; 24(1):103-13. PubMed ID: 9045296
[TBL] [Abstract][Full Text] [Related]
24. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
Nevill TJ; Hogge DE; Toze CL; Nantel SH; Power MM; Abou Mourad YR; Song KW; Lavoie JC; Forrest DL; Barnett MJ; Shepherd JD; Nitta JY; Wong S; Sutherland HJ; Smith CA
Bone Marrow Transplant; 2008 Nov; 42(10):659-66. PubMed ID: 18679372
[TBL] [Abstract][Full Text] [Related]
25. Secondary myelodysplastic syndromes and leukemias.
Giles FJ; Koeffler HP
Curr Opin Hematol; 1994 Jul; 1(4):256-60. PubMed ID: 9371291
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
[TBL] [Abstract][Full Text] [Related]
27. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.
Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE
JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657
[TBL] [Abstract][Full Text] [Related]
28. Acute myelogenous leukemia and myelodysplasia secondary to breast cancer treatment: case studies and literature review.
Cole M; Strair R
Am J Med Sci; 2010 Jan; 339(1):36-40. PubMed ID: 19996729
[TBL] [Abstract][Full Text] [Related]
29. The secondary leukemias: challenges and research directions.
Smith MA; McCaffrey RP; Karp JE
J Natl Cancer Inst; 1996 Apr; 88(7):407-18. PubMed ID: 8618232
[TBL] [Abstract][Full Text] [Related]
30. Four cases of therapy-related leukemia.
Hur M; Lee DS; Shin HY; Ahn HS; Kim BK; Cho HI
J Korean Med Sci; 1999 Jun; 14(3):327-9. PubMed ID: 10402178
[TBL] [Abstract][Full Text] [Related]
31. [Second tumors developing after therapy for malignant tumors in children].
Kuleva SA; Kolygin BA
Vopr Onkol; 2012; 58(5):606-15. PubMed ID: 23600276
[TBL] [Abstract][Full Text] [Related]
32. Are growth factors leukemogenic?
Brodsky RA; Bedi A; Jones RJ
Leukemia; 1996 Jan; 10(1):175-7. PubMed ID: 8558925
[TBL] [Abstract][Full Text] [Related]
33. United States Voluntary Children's Chemical Evaluation Program (VCCEP) risk assessment for children exposed to benzene.
Pyatt DW; Hays SM; English C; Cushing CA
Toxicol Mech Methods; 2012 Feb; 22(2):81-104. PubMed ID: 21859365
[TBL] [Abstract][Full Text] [Related]
34. Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience.
Smith RE
Clin Breast Cancer; 2003 Oct; 4(4):273-9. PubMed ID: 14651772
[TBL] [Abstract][Full Text] [Related]
35. Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.
Hijiya N; Ness KK; Ribeiro RC; Hudson MM
Cancer; 2009 Jan; 115(1):23-35. PubMed ID: 19072983
[TBL] [Abstract][Full Text] [Related]
36. Early development of acute myeloid leukemia following treatment of osteosarcoma: a case report and review of the literature.
Shen YM; Hung GY; Yen HJ; Hsieh MY; Hsieh TK
Pediatr Neonatol; 2009 Oct; 50(5):239-44. PubMed ID: 19856869
[TBL] [Abstract][Full Text] [Related]
37. Therapy-related myeloid neoplasms.
Leone G; Fianchi L; Voso MT
Curr Opin Oncol; 2011 Nov; 23(6):672-80. PubMed ID: 21918440
[TBL] [Abstract][Full Text] [Related]
38. Therapy-related acute myeloid leukemia following treatment for cancer in childhood: A population-based registry study.
Brown CA; Youlden DR; Aitken JF; Moore AS
Pediatr Blood Cancer; 2018 Dec; 65(12):e27410. PubMed ID: 30183136
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors?
Pedersen-Bjergaard J; Brøndum-Nielsen K; Karle H; Johansson B
Leukemia; 1997 Sep; 11(9):1571-4. PubMed ID: 9305614
[TBL] [Abstract][Full Text] [Related]
40. Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients.
Seif AE; Walker DM; Li Y; Huang YS; Kavcic M; Torp K; Bagatell R; Fisher BT; Aplenc R
Pediatr Blood Cancer; 2015 Apr; 62(4):704-9. PubMed ID: 24668949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
